The Centers for Medicare & Medicaid Services (CMS) recently announced a proposed rule designed to experiment with a nationwide, two-phase “Medicare Part B Drug Payment Model.” This demonstration, drafted without any stakeholder input, will adversely affect the care and treatment of GI patients with complex conditions such as Crohn’s disease and ulcerative colitis and force […]
Continue Reading >>